Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Study of NPC-01 (Lunabell) for Dysmenorrhea in Endometriosis
NCT00902746Phase 3Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- May 2009
- Primary completion
- Feb 2012
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of norethindrone + ethinyl estradiol in dysmenorrhea and endometriosis, sponsored by Nobelpharma Co., Ltd. Primary endpoint: Patient Response to Treatment for Dysmenorrhea at 52 weeks. Started May 2009; status: completed.
02
Drugs
norethindrone + ethinyl estradiol
03
Conditions
dysmenorrheaendometriosis
Beyond the preview
Go deeper on NCT00902746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00902746.